INTRACELLULAR POOLS OF THYMIDINE REDUCE THE ANTIVIRAL ACTION OF ACYCLOVIRHARMENBERG J.1983; INTERVIROLOGY; ISSN 0300-5526; CHE; DA. 1983; VOL. 20; NO 1; PP. 48-51; BIBL. 10 REF.Article

EFFECT OF ACYCLOVIR AND PRESENCE OF CELLULAR AND VIRAL THYMIDINE KINASE ACTIVITY IN HERPES SIMPLEX VIRUS INFECTED CELLSHARMENBERG J; KALLANDER CFR; GRONOWITZ JS et al.1982; ARCHIVES OF VIROLOGY; ISSN 0304-8608; AUT; DA. 1982; VOL. 74; NO 2-3; PP. 219-225; BIBL. 11 REF.Article

Comparison of the intracellular metabolism of 3'-azido-3'-deoxythymidine and 3'-fluoro-3'-deoxythymidine in lymphocytes in the presence of 5-fluoro-2'-deoxyuridineCOX, S; HARMENBERG, J.Antiviral chemistry & chemotherapy. 1990, Vol 1, Num 2, pp 155-161, issn 0956-3202, 7 p.Article

A NOVEL METHOD FOR DETERMINING THE SENSITIVITY OF HERPES SIMPLEX VIRUS TO ANTIVIRAL COMPOUNDSWAHREN B; HARMENBERG J; SUNDQVIST VA et al.1983; JOURNAL OF VIROLOGICAL METHODS; ISSN 0166-0934; NLD; DA. 1983; VOL. 6; NO 3; PP. 141-149; BIBL. 21 REF.Article

Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1KARLSSON, A; HARMENBERG, J.Antimicrobial agents and chemotherapy. 1988, Vol 32, Num 7, pp 1100-1102, issn 0066-4804Article

Synergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidinePALMER, S; HARMENBERG, J; COX, S et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 5, pp 1285-1288, issn 0066-4804Article

Deoxythymidine pools in animal and human skin with reference to antiviral drugsHARMENBERG, J; ABELE, G; MALM, M et al.Archives of dermatological research (Print). 1985, Vol 277, Num 5, pp 402-403, issn 0340-3696Article

Improved sample preparation method for high-performance liquid chromatography of deoxyribonucleoside triphosphates from cell culture extractsHARMENBERG, J; COX, S; AKESSON-JOHANSSON, A et al.Journal of chromatography. 1990, Vol 508, Num 1, pp 75-79, issn 0021-9673, 5 p.Article

Nucleoside pools of acyclovir-treated herpes simplex type 1 infected cellsHARMENBERG, J; ABELE, G; WAHREN, B et al.Antiviral research. 1985, Vol 5, Num 2, pp 75-81, issn 0166-3542Article

Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogsHARMENBERG, J; WAHREN, B; BERGMAN, J et al.Antimicrobial agents and chemotherapy. 1988, Vol 32, Num 11, pp 1720-1724, issn 0066-4804Article

Herpes simplex virus zosteriform lesions with adoptive transfer of immune cells : a murine model which mimics human recurrent diseaseAWAN, A. R; HARMENBERG, J; KRISTOFFERSON, A et al.Antiviral research. 1998, Vol 38, Num 1, pp 43-53, issn 0166-3542Article

Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compoundsHARMENBERG, J; WAHREN, B; SUNDQVIST, V.-A et al.Journal of antimicrobial chemotherapy (Print). 1985, Vol 15, Num 5, pp 567-573, issn 0305-7453Article

Combinations of antiviral and anti-inflammatory preparations for the topical treatment of herpes simplex virus assessed using a murine zosteriform infection modelAWAN, A. R; HARMENBERG, J; FLINK, O et al.Antiviral chemistry & chemotherapy. 1998, Vol 9, Num 1, pp 19-24, issn 0956-3202Article

Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2Hm-HBG) and other antiviral compoundsAKESSON-JOHANSSON, A; HARMENBERG, J; WAHREN, B et al.Antimicrobial agents and chemotherapy. 1990, Vol 34, Num 12, pp 2417-2419, issn 0066-4804, 3 p.Article

Influence of acyclovir and bucyclovir on nucleotide pools in cells infected with herpes simplex virus type 1KARLSSON, A. H. J; HARMENBERG, J. G; WAHREN, B. E et al.Antimicrobial agents and chemotherapy. 1986, Vol 29, Num 5, pp 821-824, issn 0066-4804Article

Comparative methods for detection of thymidine kinase-deficient herpes simplex virus type 1 strainsHARMENBERG, J; SUNDQVIST, V.-A; GADLER, H et al.Antimicrobial agents and chemotherapy. 1986, Vol 30, Num 4, pp 570-573, issn 0066-4804Article

Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnetKOSHIDA, R; VRANG, L; GILLJAM, G et al.Antimicrobial agents and chemotherapy. 1989, Vol 33, Num 5, pp 778-780, issn 0066-4804Article

Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl] guanine on varicella-zoster virus replication in cell cultureABELE, G; KARLSTROM, A; HARMENBERG, J et al.Antimicrobial agents and chemotherapy. 1987, Vol 31, Num 1, pp 76-80, issn 0066-4804Article

Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialisEVANS, T. G; BERNSTEIN, D. I; RABORN, G. W et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 6, pp 1870-1874, issn 0066-4804Article

Herpes simplex virus type 1 infection and glucocorticoid treatment regulate viral yield, glucocorticoid receptor and NF-κB levelsERLANDSSON, A. C; BLADH, L.-G; STIERNA, P et al.Journal of endocrinology. 2002, Vol 175, Num 1, pp 165-176, issn 0022-0795, 12 p.Article

The mechanism of action of the anti-herpes virus compound 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxalineHARMENBERG, J; AKESSON-JOHANSSON, A; GRASLUND, A et al.Antiviral research. 1991, Vol 15, Num 3, pp 193-204, issn 0166-3542, 12 p.Article